ECB targets summer deadline for digital euro rules
The European Central Bank aims to finalise key technical standards for a potential digital euro by this summer, allowing banks and merchants to begin preparing their systems.

Finance journalist at Grafa. Covers tech, crypto, and markets, making complex finance clear for all. Passionate about innovation and trends.
The European Central Bank aims to finalise key technical standards for a potential digital euro by this summer, allowing banks and merchants to begin preparing their systems.
US lawmakers are evaluating how tokenised securities should be regulated, with industry executives urging that existing investor protection and financial surveillance laws remain in place.
US lawmakers are moving closer to regulating tokenised securities, with a House hearing highlighting growing consensus that blockchain-based trading will require the same safeguards as traditional markets.
Bitcoin has rebounded about 12% to $71,012 since the Iran conflict began, challenging its earlier weakness but failing to confirm a safe-haven role.
Japan warns Australia that a proposed LNG windfall tax could cripple investment and strain relations amid the Middle East energy crisis.
Koonenberry Gold (ASX:KNB) announced a high-grade gold visualisations and assay results from its ongoing exploration efforts at the Enmore Project.
CIMG (NASDAQ:IMG), a business group specializing in digital health and technology-driven sales development, announced its financial results for the first quarter ended December 31, 2025.
ProMIS Neurosciences (NASDAQ:PMN), a biotechnology company developing antibody therapeutics for neurodegenerative diseases, reported its full-year 2025 financial results and provided a comprehensive corporate update on March 25, 2026.
Lockheed Martin (NYSE:LMT) and the U.S. Department of War (DoW) announced a landmark framework agreement on March 25, 2026, to dramatically accelerate the manufacturing of Precision Strike Missiles (PrSM).
Merck (NYSE:MRK), known as MSD outside the U.S. and Canada, has entered into a definitive agreement to acquire clinical-stage oncology firm Terns Pharmaceuticals (NASDAQ:TERN) for approximately $6.7 billion in equity value.